Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP248666.RAeDwVTkj8iNKJKexoN0km0jf-fCO968I1HQ0TtQYMysI130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248666.RAeDwVTkj8iNKJKexoN0km0jf-fCO968I1HQ0TtQYMysI130_provenance.
• NP395305.RAU0SRPkx6SSo-soBR6_pzXKkxIQwk-djslNRekVv1G0A130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395305.RAU0SRPkx6SSo-soBR6_pzXKkxIQwk-djslNRekVv1G0A130_provenance.
• NP395432.RAfTdNfr2dj2o0rLtztq8D8dSKobsp5wkXXsvl7pO3Tqo130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395432.RAfTdNfr2dj2o0rLtztq8D8dSKobsp5wkXXsvl7pO3Tqo130_provenance.
• NP515096.RAfpYZ8KWtGRBnA_Goyqd6NcPaa6laTVT_CJ09GtZkxss130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515096.RAfpYZ8KWtGRBnA_Goyqd6NcPaa6laTVT_CJ09GtZkxss130_provenance.
• NP515102.RAXld__pzEBVoqq2A3ECuxsJYwCH3N2FpHdgmnrsNLLhE130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515102.RAXld__pzEBVoqq2A3ECuxsJYwCH3N2FpHdgmnrsNLLhE130_provenance.
• NP248583.RAjOISeIj7c1uLlMDsdAaRZoGXjTIfKc6eC59SZ7aA-w0130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248583.RAjOISeIj7c1uLlMDsdAaRZoGXjTIfKc6eC59SZ7aA-w0130_provenance.
• NP248725.RAm3EsGh3U_W9Lzk3ZS_lUOCgMVNrR60EBSdq3PkyE7Ro130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248725.RAm3EsGh3U_W9Lzk3ZS_lUOCgMVNrR60EBSdq3PkyE7Ro130_provenance.
• NP395016.RAlJKpNPi-8ZKZcTg0XwYhrH3XEu8V05rsB3v6H8jp_b8130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395016.RAlJKpNPi-8ZKZcTg0XwYhrH3XEu8V05rsB3v6H8jp_b8130_provenance.
• NP515098.RAjI-ltObZO60MuV9-nX-pLmF_0j5CS0twk8shj96l_w4130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515098.RAjI-ltObZO60MuV9-nX-pLmF_0j5CS0twk8shj96l_w4130_provenance.
• NP248222.RA8u9Eoo2KHPrFPTY33_IOi9BbJnCj8h6JlGinrZD6Mz0130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248222.RA8u9Eoo2KHPrFPTY33_IOi9BbJnCj8h6JlGinrZD6Mz0130_provenance.
• NP395256.RA4ZQv4XYVZjtUMi1MM1AVLuFQeVZ8U1gqeorjESTKeIA130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395256.RA4ZQv4XYVZjtUMi1MM1AVLuFQeVZ8U1gqeorjESTKeIA130_provenance.
• NP395380.RA9RPcax9SloCCk9U6TMbSgHZrx7Qif3bPUVsZXZP2f_Y130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395380.RA9RPcax9SloCCk9U6TMbSgHZrx7Qif3bPUVsZXZP2f_Y130_provenance.
• NP248539.RAEo4xrI-4KOBzWBFBKvMSHSDY1gDTy9eclFgmmRay8Og130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248539.RAEo4xrI-4KOBzWBFBKvMSHSDY1gDTy9eclFgmmRay8Og130_provenance.
• NP515100.RAJn_No9oSMHGMHFyO5l3g_jk846ShJmmzpFx61x1zlCE130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515100.RAJn_No9oSMHGMHFyO5l3g_jk846ShJmmzpFx61x1zlCE130_provenance.
• NP515107.RAG6diVTDlh3nIY8NeHp4uCjut4O5XcfpG0zMCK9ClFFQ130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515107.RAG6diVTDlh3nIY8NeHp4uCjut4O5XcfpG0zMCK9ClFFQ130_provenance.
• NP515097.RA3pkV2D3BDStCZ69DWE7Lr-NwHZremNajSoKNNb_DJRA130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515097.RA3pkV2D3BDStCZ69DWE7Lr-NwHZremNajSoKNNb_DJRA130_provenance.
• NP515103.RAy1de37MZr42yRK0eVqa1CU3Hf5k2rfi3LZadR2w3CuM130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515103.RAy1de37MZr42yRK0eVqa1CU3Hf5k2rfi3LZadR2w3CuM130_provenance.
• NP515104.RA1NxGCSW0Ht6IrCKiRd0LcLgvt36cL2OH6k3eCpoC_N0130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515104.RA1NxGCSW0Ht6IrCKiRd0LcLgvt36cL2OH6k3eCpoC_N0130_provenance.
• NP515105.RA39UgtQWTGw7yhIAZoE3RxXgk0HYfcMKhoZRbVWE1lQQ130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515105.RA39UgtQWTGw7yhIAZoE3RxXgk0HYfcMKhoZRbVWE1lQQ130_provenance.
• NP515109.RA4hHKGSIZ-p5DDvCF78K-RzWnrTM52sTZA5BolkOwn9o130_assertion description "[42:479-484) that functional polymorphisms in FAS and FAS ligand (FASL) are associated with susceptibility to lung cancer and esophageal cancer; however, the mechanisms underlying this association have not been elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515109.RA4hHKGSIZ-p5DDvCF78K-RzWnrTM52sTZA5BolkOwn9o130_provenance.